Study ID: TV48125-CNS-30058 | 2016-003172-43

Study Title

A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache

Teva Identifier

TV48125-CNS-30058 | 2016-003172-43

ClinicalTrials.gov Identifier

NCT03107052

Study Status

Terminated

Trial Condition(s)

Cluster Headache

Interventions

Drug: Fremanezumab

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 70 Years

Trial Duration

April 27, 2017 - June 11, 2019

Phase

Phase 3

Study Type

Interventional